vs
Side-by-side financial comparison of Twin Hospitality Group Inc. (TWNP) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Twin Hospitality Group Inc. is the larger business by last-quarter revenue ($82.3M vs $70.6M, roughly 1.2× Viridian Therapeutics, Inc.\DE). Twin Hospitality Group Inc. runs the higher net margin — -29.7% vs -49.0%, a 19.3% gap on every dollar of revenue. Twin Hospitality Group Inc. produced more free cash flow last quarter ($-7.4M vs $-84.7M).
Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
TWNP vs VRDN — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $82.3M | $70.6M |
| Net Profit | $-24.5M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | -16.2% | -56.7% |
| Net Margin | -29.7% | -49.0% |
| Revenue YoY | — | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.43 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $82.3M | $70.6M | ||
| Q2 25 | $87.8M | — | ||
| Q1 25 | $87.1M | — |
| Q3 25 | $-24.5M | $-34.6M | ||
| Q2 25 | $-20.8M | — | ||
| Q1 25 | $-12.1M | — |
| Q3 25 | -16.2% | -56.7% | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -1.2% | — |
| Q3 25 | -29.7% | -49.0% | ||
| Q2 25 | -23.7% | — | ||
| Q1 25 | -13.9% | — |
| Q3 25 | $-0.43 | — | ||
| Q2 25 | $-0.38 | — | ||
| Q1 25 | $-0.26 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | $402.8M | — |
| Stockholders' EquityBook value | $-92.1M | $503.0M |
| Total Assets | $516.8M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — |
| Q3 25 | $402.8M | — | ||
| Q2 25 | $411.3M | — | ||
| Q1 25 | $413.0M | — |
| Q3 25 | $-92.1M | $503.0M | ||
| Q2 25 | $-78.6M | — | ||
| Q1 25 | $-101.9M | — |
| Q3 25 | $516.8M | $577.1M | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $544.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.9M | $-84.6M |
| Free Cash FlowOCF − Capex | $-7.4M | $-84.7M |
| FCF MarginFCF / Revenue | -9.0% | -120.1% |
| Capex IntensityCapex / Revenue | 1.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-5.9M | $-84.6M | ||
| Q2 25 | $-8.8M | — | ||
| Q1 25 | $-5.7M | — |
| Q3 25 | $-7.4M | $-84.7M | ||
| Q2 25 | $-10.6M | — | ||
| Q1 25 | $-9.7M | — |
| Q3 25 | -9.0% | -120.1% | ||
| Q2 25 | -12.1% | — | ||
| Q1 25 | -11.2% | — |
| Q3 25 | 1.9% | 0.2% | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
